Opko Health Inc (NASDAQ: OPK) has seen a decline in its stock price by 0.00 in relation to its previous close of 1.30. However, the company has experienced a 3.17% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-05-03 that MIAMI, May 03, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time.
Is It Worth Investing in Opko Health Inc (NASDAQ: OPK) Right Now?
Moreover, the 36-month beta value for OPK is 1.75. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for OPK is 327.73M and currently, short sellers hold a 23.81% of that float. On May 06, 2024, OPK’s average trading volume was 8.71M shares.
OPK’s Market Performance
OPK’s stock has seen a 3.17% increase for the week, with a -4.41% drop in the past month and a 30.65% gain in the past quarter. The volatility ratio for the week is 4.66%, and the volatility levels for the past 30 days are at 4.74% for Opko Health Inc The simple moving average for the last 20 days is 2.83% for OPK stock, with a simple moving average of -5.21% for the last 200 days.
Analysts’ Opinion of OPK
Many brokerage firms have already submitted their reports for OPK stocks, with Barrington Research repeating the rating for OPK by listing it as a “Outperform.” The predicted price for OPK in the upcoming period, according to Barrington Research is $2 based on the research report published on June 29, 2023 of the previous year 2023.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPK reach a price target of $3. The rating they have provided for OPK stocks is “Buy” according to the report published on December 15th, 2022.
OPK Trading at 16.57% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.96% of loss for the given period.
Volatility was left at 4.74%, however, over the last 30 days, the volatility rate increased by 4.66%, as shares sank -3.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +34.01% upper at present.
During the last 5 trading sessions, OPK rose by +3.17%, which changed the moving average for the period of 200-days by -39.53% in comparison to the 20-day moving average, which settled at $1.2617. In addition, Opko Health Inc saw -13.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from FROST PHILLIP MD ET AL, who purchase 500,000 shares at the price of $0.87 back on Mar 18 ’24. After this action, FROST PHILLIP MD ET AL now owns 210,968,225 shares of Opko Health Inc, valued at $437,100 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 500,000 shares at $0.89 during a trade that took place back on Mar 14 ’24, which means that FROST PHILLIP MD ET AL is holding 210,468,225 shares at $444,300 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.18 for the present operating margin
- 0.34 for the gross margin
The net margin for Opko Health Inc stands at -0.22. The total capital return value is set at -0.09. Equity return is now at value -12.80, with -9.04 for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.11. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is 3488.33.
Currently, EBITDA for the company is -52.76 million with net debt to EBITDA at -2.75. When we switch over and look at the enterprise to sales, we see a ratio of 1.32. The receivables turnover for the company is 6.63for trailing twelve months and the total asset turnover is 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.55.
Conclusion
To wrap up, the performance of Opko Health Inc (OPK) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
